To make things easier, leave this box checked On shared devices, we recommend that you disconnect from Euroquity when you are done
Email

You will receive an email to define a new password

Location

Select your country

and your language

Hi ,

Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.

% completed

%

medal 2
This profile is validated by 2 label.

Company

React4life srl

React4life srl_logo
41
EQ SCORE

The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.

React4life was launched in 2016 as innovative startup company by a team of scientists and promoters of breakthrough technologies. Our mission is creating solutions to transform the promise of biomedical research in concrete benefits for the mankind.

Milano, Lombardia, Italy

Send a message

English

React4life srl

English

React4life has developed MIVO® - Multi In Vitro Organ, an innovative microphysiological system able to emulate portions of the human body in vitro. It can be used (i) for enhancing tissues conditions and prolonging lifetime of cells ex vivo towards personalized medicine, (ii) for advanced drug/ new therapeutic approaches testing, and (iii) for basic research to accelerate human disease knowledge, finally reducing the animal use. MIVO is patented, fully industrialized and...

See more

React4life has developed MIVO® - Multi In Vitro Organ, an innovative microphysiological system able to emulate portions of the human body in vitro. It can be used (i) for enhancing tissues conditions and prolonging lifetime of cells ex vivo towards personalized medicine, (ii) for advanced drug/ new therapeutic approaches testing, and (iii) for basic research to accelerate human disease knowledge, finally reducing the animal use. MIVO is patented, fully industrialized and already sold to pharma, research centers, CRO and testing companies.

MIVO represents a step-forward with respect to all the current in vitro assays, due to its unique capacity to culture 3D clinically-relevant size tissues (organoids, bioprinted tissues or patient derived biopsies) under physiological fluid-flow. This solution represents a cutting-edge technology since it shows high reliability when performing realistic and reproducible tests in a physiological 3D environment (results in line with animal/clinical data), (ii) it is quick and easy to use (less than 2 minute to start the experiments), (iii) it is flexible and allows multi-chamber connection, for ADME assays and multi-organ based disease modelling, (iv) it provides fast test-response with respect to other pre-clinical studies (75% time reduction in drug efficacy assays).

  • 3

    Followers

  • 3

    Like

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

Seal of Excellence
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not receive funding due to budget limits. This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1481 Entities
InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
454 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Members
Access2EIC
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors. https://access2eic.eu/
2140 Members